Subscribe to one of our feedsfont size
PrintEditor's Picks
Back « 1 2 3 4 5 6 7 8 ... » Next
- For the Brain, Remembering Is Like Reliving
The New York Times - Arthritis Drugs Linked to Risks From Infection
The New York Times - Cancer Researchers Should Widen Genetic Focus, Studies Suggest
Bloomberg - Down's signs 'seen in stem cells'
BBC - Pfizer invests in S.F. biotech firm's drug
The San Francisco Chronicle - U.S. study clears measles vaccine of autism link
Reuters - Biotech group not endorsing for prez, but seeks more in FDA budget
The Boston Herald - In Studies of Virtual Twins, Nature Wins Again
The New York Times - Czech city bids to be global biotech hub
Reuters - Biofuel researchers look for the good in stinkweed
The Associated Press - For Widely Used Drug, Question of Usefulness Is Still Lingering
The New York Times - VC Funding for Biotech Companies Withering
GEN - Pfizer Acquires Rights to Alzheimer's Drug
The New York Times - A Regeneron Drug Minimized Recurrence of Gout in Clinical Trial
The New York Times - Marriage problems? Husband's genes may be to blame
Reuters - High blood calcium tied to lethal prostate cancer
Reuters - Big pharma gravitates to the academe
Financial Times - Cancer, diabetes leave fingerprints in blood, serum
Reuters - Google's Philanthropy Arm Leads Effort to Use Weather Data to Fight Disease
The New York Times - Doubts Grow Over Flu Vaccine in Elderly
The New York Times - Shionogi to Buy Sciele Pharma to Get U.S. Sales Staff
Bloomberg - Cracking enzyme code opens way to new cancer drugs
AFP - Obesity not a red flag for spotting diabetes
Reuters - Bringing Good Things To Life (Science)?
The Scientists - GSK signs $820M drug development deal
Triangle Business Journal - Sleep quality drops with age, but effects diminish
Reuters - Antipsychotic drugs double stroke risk: study
Reuters - Independent WHO study backs universal health care
Reuters - H.I.V. Is Spreading in New York City at Three Times the National Rate, a Study Finds
The New York Times - Deafness breakthrough as doctor grows critical cell type
The Times - Amgen to Stop Offering Discounts on Anemia Drug
Reuters - Fertility treatments induce gene mutations: study
Reuters - Scientists Reprogram Adult Cells' Function
The Washington Post - Survey finds causes of cancer little understood
Reuters - Novartis' Glivec gets FDA priority review
Reuters - Biologist Doug Melton talks about how disease-specific stem cells will reshape medicine
Technology Review - Novavax Moves Closer to Licensing Bird Flu Vaccine
The Washington Post - Census: Number of uninsured dropped in 2007
MSNBC - California stop-smoking campaign saved $86 billion: report
Reuters - Stanford to Limit Drug Maker Financing
The New York Times - Cancer Test for Women Raises Hope, and Concern
The New York Times - Two experiments suggest new direction for diabetes
Reuters - Uninsured pay $30 billion for health care
Reuters - Gilead's hiring plan: 1,900 new jobs
The San Francisco Business Times - Gastric bypass surgery reverses metabolic syndrome
Reuters - Human exoskeleton suit helps paralyzed people walk
Reuters - FDA approves Amgen drug Nplate to treat blood clotting disorder
The Los Angeles Times - Measles Cases Grow in Number, and Officials Blame Parents' Fear of Autism
The New York Times - Drugmakers Given Legal Shield By Rule, Lawyers Say
Bloomberg - Genentech to Pay Retention Bonuses
The New York Times - Judge Orders Drug Maker to Provide Experimental Treatment to Terminally Ill Teenager
The New York Times - DHEA may not boost brain power, well-being
Reuters - Report Rejects Medicare Boast of Paring Fraud
The New York Times - Biotech buyout action likely to continue
CNNMoney - Stem-cell, state reform get enough signatures
Detroit Free Press - Vaccine refusals fuel measles outbreak
Reuters - "Good" fat may be new weapon in obesity fight
Reuters - Researchers Question Wide Use of HPV Vaccines
The New York Times - Judge Orders Drug Maker to Provide Experimental Treatment to Terminally Ill Teenager
The New York Times - Matsushita says new DNA technology identifies disease risks
AFP - NIST study helps stabilize protein drugs
UPI - California Licenses 2 Companies to Offer Gene Services
The New York Times - Drug Makers' Push Leads to Cancer Vaccines' Fast Rise
The New York Times - Medicine tailored to your genome, not your race: Venter
AFP - Consumers face rising medical debt: survey
Reuters - Researchers produce blood in lab from stem cells
The Los Angeles Times - Stem cell test to help treat bowel cancer
Reuters - Novo Nordisk Expects Stronger Warning Requirements From FDA
Bloomberg - Arsenic has firm link to diabetes in U.S. study
Reuters - Merck Vioxx study was for marketing: researchers
Reuters - At Meeting on AIDS, Focus Shifts to Long Haul
The New York Times - Better to Be Fat and Fit Than Skinny and Unfit
The New York Times - An Advocate for Science Diplomacy
The New York Times - US senators optimistic about ethanol, ag futures
CNNMoney - Psychologists Clash on Aiding Interrogations
The New York Times - First US drug for Huntington's disease wins approval
The Associated Press - Methadone Rises as a Painkiller With Big Risks
The New York Times - For Bristol, steady course may be best navigation
Reuters - Antibodies still protect 1918 flu survivors: study
Reuters - Study links genetic traits to bipolar disorder
Reuters - Biotech Campaigns for Easier Access to Generic Drug Market
The Washington Post - H9N2 bird flu threat understated in humans
Reuters - High PCB exposure tied to diabetes risk
Reuters - Pfizer May Pay Cytos SF150 Million for Vaccine Access
Bloomberg - Researchers find gene link to colon cancer: study
AFP - Transplant Study Revives Questions Over When to Declare Donors Dead
The New York Times - British scientists test first arthritis vaccine
Reuters - Life sciences firms anxious about rules on gifts to doctors
The Boston Globe - Radiation can zap cancer that has spread: study
Reuters - Said the Doctor to the Cancer Patient: Hit the Gym
The New York Times - Prince accused of 'Luddite' attack on biocrops
Financial Times - Genentech Rejects Takeover Bid From Roche
The New York Times - "Elite" HIV wife may hold secret to AIDS vaccine
Reuters - CSL to Buy Talecris for $3.1 Billion in Record Buyout
Bloomberg - Scientists claim breakthrough in understanding common form of dementia
The Daily Telegraph - New drug rulings may confuse investors
Reuters - Los Angeles Stages a Fast Food Intervention
The New York Times - Faith slipping in meaningful Pfizer deal
Reuters - Fit and fat: Study shows it's possible
Reuters - Low vitamin D shown to raise death risk: U.S. study
Reuters
Back « 1 2 3 4 5 6 7 8 ... » Next
- Thousands of cancer patients could be denied a new drug
The Telegraph - Pension plan sues to stop Lilly buyout of ImClone
Reuters - A Rise in Kidney Stones Is Seen in U.S. Children
The New York Times - US warns Bayer over aspirins containing supplements
Reuters - UCC debate to fuel calls for national stem cell policy
Irish Times - Total artificial heart to be ready by 2011: research team
AFP - Credit crunch threatens investment in medicines
The Times - Quickly Vetted, Treatment Is Offered to Patients
The New York Times - Businesses Wary of Details in Obama Health Plan
The New York Times - Sales of Test for Ovarian Cancer Halted
The New York Times